EnPlusOne Biosciences
PrivateLast Round
VC Round
Feb 19, 2025
Total Funding Raised
$12M
Company Overview
EnPlusOne Biosciences operates in Healthcare & Life Sciences and is based in Watertown, Massachusetts. Its latest recorded funding round was a VC Round in February 2025.
EnPlusOne Biosciences is a biotechnology company that developed ezRNA™, an enzymatic-based RNA synthesis platform designed to manufacture RNA oligonucleotides for therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EnPlusOne Biosciences Comparables
Compare EnPlusOne Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sensible Biotechnologies | 77% | |
| Codexis | 74% | |
| Ribbon Bio | 72% |
For institutional investors. Book with your work email.
EnPlusOne Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 19, 2025 | ||||
| Seed | Sep 30, 2022 |
For institutional investors. Book with your work email.
EnPlusOne Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Northpond Ventures | VC Round, Seed |
| Breakout Ventures | Seed, VC Round |
| Coatue Management | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors increased 66% MoM, reaching 1K.
- Mar 3, 2026
Monthly visitors increased 30% MoM.
For institutional investors. Book with your work email.
EnPlusOne Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EnPlusOne Biosciences's valuation, stock price, and market status.
Is EnPlusOne Biosciences a public or private company?
EnPlusOne Biosciences is a private company.
What is the current stock price of EnPlusOne Biosciences?
EnPlusOne Biosciences is a private company, so its shares have no public market price. Caplight tracks EnPlusOne Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EnPlusOne Biosciences worth (valuation)?
Valuation information for EnPlusOne Biosciences is not publicly available.
Can I buy EnPlusOne Biosciences stock?
EnPlusOne Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EnPlusOne Biosciences's last funding round?
EnPlusOne Biosciences's most recent funding round was VC Round on February 19, 2025.
Who are the main investors in EnPlusOne Biosciences?
Key investors in EnPlusOne Biosciences include Northpond Ventures, Breakout Ventures.
Will EnPlusOne Biosciences IPO soon?
No public IPO plans have been announced for EnPlusOne Biosciences.
How can I track EnPlusOne Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in EnPlusOne Biosciences's shares on secondary markets.